IRadimed posts 3Q profit Mon, 30 Oct 2017 11:19:46 +0000 On a per-share basis, the Winter Springs, Florida-based company said it had net income of 2 cents. Earnings, adjusted for stock option expense, came to 7 cents per share. The maker of IV devices that can ...
iRadimed Corp to Host Earnings Call Mon, 30 Oct 2017 11:10:00 +0000 NEW YORK, NY / ACCESSWIRE / October 30, 2017 / iRadimed Corp (NASDAQ: IRMD ) will be discussing their earnings results in their Q3 Earnings Call to be held on October 30, 2017 at 11:00 AM Eastern Time. ...
IRADIMED CORPORATION Announces Third Quarter 2017 Financial Results Mon, 30 Oct 2017 11:00:00 +0000 Reports third quarter 2017 revenue of $5.7 million Reports third quarter 2017 GAAP diluted EPS of $0.02 and non-GAAP diluted EPS of $0.07 Increases full year 2017 non-GAAP diluted EPS guidance. WINTER ...
ETFs with exposure to IRadimed Corp. : October 27, 2017 Fri, 27 Oct 2017 15:00:47 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to IRadimed Corp. Here are 5 ETFs with the largest exposure to IRMD-US. Comparing the performance and risk of IRadimed Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
IRadimed Corp.: Price momentum supported by strong fundamentals Fri, 27 Oct 2017 14:28:22 +0000 Categories: Yahoo FinanceIRadimed Corp. relative valuation is NEUTRAL and it has a fundamental analysis score of 81. Our analysis is based on comparing IRadimed Corp. with the following peers – AtriCure, Inc., Milestone Scientific Inc., Cooper Companies, Inc. and DexCom, Inc. (ATRC-US, MLSS-US, COO-US and DXCM-US). IRadimed Corp. has shown good performance overall, both over the last ... Read more
(Read more...)
ETFs with exposure to IRadimed Corp. : September 26, 2017 Tue, 26 Sep 2017 14:55:02 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to IRadimed Corp. Here are 5 ETFs with the largest exposure to IRMD-US. Comparing the performance and risk of IRadimed Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
IRadimed Corp. :IRMD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 25, 2017 Mon, 25 Sep 2017 12:52:17 +0000 Categories: Yahoo FinanceGet free summary analysis IRadimed Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of IRadimed Corp. – AtriCure, Inc., Milestone Scientific Inc., Cooper Companies, Inc. and DexCom, Inc. (ATRC-US, MLSS-US, COO-US and DXCM-US) that have also reported for this period. Highlights Summary numbers: ... Read more
(Read more...)
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.